• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在克罗恩病患者的诊断中,结肠活检的组织病理学特征可预测长期疾病过程。

Histopathological Features in Colonic Biopsies at Diagnosis Predict Long-term Disease Course in Patients with Crohn's Disease.

机构信息

Department of Internal Medicine, Division of Gastroenterology and Hepatology, Maastricht University Medical Center+, Maastricht, The Netherlands.

School for Nutrition and Translational Research in Metabolism, Maastricht University Medical Center+, Maastricht, The Netherlands.

出版信息

J Crohns Colitis. 2021 Nov 8;15(11):1885-1897. doi: 10.1093/ecco-jcc/jjab087.

DOI:10.1093/ecco-jcc/jjab087
PMID:33987670
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8575048/
Abstract

BACKGROUND AND AIMS

Crohn's disease [CD] is characterised by a heterogeneous disease course. Patient stratification at diagnosis using clinical, serological, or genetic markers does not predict disease course sufficiently to facilitate clinical decision making. The current study aimed to investigate the additive predictive value of histopathological features to discriminate between a long-term mild and severe disease course.

METHODS

Diagnostic biopsies from treatment-naïve CD patients with mild or severe disease courses in the first 10 years after diagnosis were reviewed by two gastrointestinal pathologists after developing a standardised form comprising 15 histopathological features. Multivariable logistic regression models were built to identify predictive features and compute receiver operating characteristic [ROC] curves. Models were internally validated using bootstrapping to obtain optimism-corrected performance estimates.

RESULTS

In total, 817 biopsies from 137 patients [64 mild, 73 severe cases] were included. Using clinical baseline characteristics, disease course could only moderately be predicted (area under receiver operating characteristic curve [AUROC]: 0.738 [optimism 0.018], 95% confidence interval [CI] 0.65-0.83, sensitivity 83.6%, specificity 53.1%). When adding histopathological features, in colonic biopsies a combination of [1] basal plasmacytosis, [2] severe lymphocyte infiltration in lamina propria, [3] Paneth cell metaplasia, and [4] absence of ulcers were identified and resulted in significantly better prediction of a severe course (AUROC: 0.883 [optimism 0.033], 95% CI 0.82-0.94, sensitivity 80.4%, specificity 84.2%).

CONCLUSIONS

In this first study investigating the additive predictive value of histopathological features in biopsies at CD diagnosis, we found that certain features of chronic inflammation in colonic biopsies contributed to prediction of a severe disease course, thereby presenting a novel approach to improving stratification and facilitating clinical decision making.

摘要

背景与目的

克罗恩病(CD)的病程具有异质性。在诊断时使用临床、血清学或遗传标志物对患者进行分层,并不能充分预测疾病的病程,从而无法为临床决策提供便利。本研究旨在探讨组织病理学特征对区分长期轻度和重度病程的附加预测价值。

方法

对诊断时处于轻度或重度病程的治疗初治 CD 患者的诊断性活检进行回顾性研究,由两位胃肠病病理学家在制定了包含 15 个组织病理学特征的标准表格后进行评估。采用多变量逻辑回归模型来识别预测特征并计算受试者工作特征(ROC)曲线。使用 bootstrap 进行内部验证,以获得矫正后的模型性能估计。

结果

共纳入了 137 例患者的 817 份活检标本[64 份轻度,73 份重度病例]。使用临床基线特征,仅能对病程进行中度预测(ROC 曲线下面积 [AUROC]:0.738 [矫正后 0.018],95%置信区间 [CI] 0.65-0.83,敏感性 83.6%,特异性 53.1%)。当加入组织病理学特征时,在结肠活检中,[1]基底浆细胞增多、[2]固有层严重淋巴细胞浸润、[3]潘氏细胞化生和[4]无溃疡这四种特征的组合被确定,并可显著改善对重度病程的预测(AUROC:0.883 [矫正后 0.033],95% CI 0.82-0.94,敏感性 80.4%,特异性 84.2%)。

结论

本研究首次探讨了在 CD 诊断时活检组织病理学特征的附加预测价值,发现结肠活检中某些慢性炎症特征有助于预测严重的病程,从而为改善分层和为临床决策提供便利提供了一种新方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80f2/8575048/cb0469b38661/jjab087f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80f2/8575048/e85e1c5aeab1/jjab087f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80f2/8575048/cb0469b38661/jjab087f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80f2/8575048/e85e1c5aeab1/jjab087f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80f2/8575048/cb0469b38661/jjab087f0002.jpg

相似文献

1
Histopathological Features in Colonic Biopsies at Diagnosis Predict Long-term Disease Course in Patients with Crohn's Disease.在克罗恩病患者的诊断中,结肠活检的组织病理学特征可预测长期疾病过程。
J Crohns Colitis. 2021 Nov 8;15(11):1885-1897. doi: 10.1093/ecco-jcc/jjab087.
2
Endoscopic biopsy features and diagnostic challenges of adult Crohn's disease at initial presentation.成人克罗恩病初次就诊时的内镜活检特征和诊断挑战。
Pathology. 2010 Feb;42(2):131-7. doi: 10.3109/00313020903494979.
3
Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC.基于 SONIC 数据的事后分析验证克罗恩病患者内镜活动评分的有效性。
Gastroenterology. 2013 Nov;145(5):978-986.e5. doi: 10.1053/j.gastro.2013.08.010. Epub 2013 Aug 14.
4
Morphologic criteria applicable to biopsy specimens for effective distinction of inflammatory bowel disease from other forms of colitis and of Crohn's disease from ulcerative colitis.适用于活检标本的形态学标准,以有效区分炎症性肠病与其他形式的结肠炎,以及克罗恩病与溃疡性结肠炎。
Scand J Gastroenterol. 1999 Jan;34(1):55-67. doi: 10.1080/00365529950172844.
5
Histopathological parameters as predictors for the course of Crohn's disease.组织病理学参数作为克罗恩病病程的预测指标
Virchows Arch. 2003 Oct;443(4):501-7. doi: 10.1007/s00428-003-0863-6. Epub 2003 Jul 24.
6
Quantitative assessment of CD30+ lymphocytes and eosinophils for the histopathological differential diagnosis of inflammatory bowel disease.用于炎症性肠病组织病理学鉴别诊断的CD30 +淋巴细胞和嗜酸性粒细胞的定量评估
J Crohns Colitis. 2015 Sep;9(9):763-8. doi: 10.1093/ecco-jcc/jjv097. Epub 2015 Jun 5.
7
Multigene analysis can discriminate between ulcerative colitis, Crohn's disease, and irritable bowel syndrome.多基因分析能够区分溃疡性结肠炎、克罗恩病和肠易激综合征。
Gastroenterology. 2008 Jun;134(7):1869-81; quiz 2153-4. doi: 10.1053/j.gastro.2008.02.083. Epub 2008 Mar 2.
8
Profiles of Lamina Propria T Helper Cell Subsets Discriminate Between Ulcerative Colitis and Crohn's Disease.固有层辅助性T细胞亚群特征可区分溃疡性结肠炎和克罗恩病。
Inflamm Bowel Dis. 2016 Aug;22(8):1779-92. doi: 10.1097/MIB.0000000000000811.
9
Risk Stratification of Patients with Crohn's Disease: A Retrospective Analysis of Clinical Decision Making and Its Impact on Long-Term Outcome.克罗恩病患者的风险分层:临床决策制定及其对长期结局影响的回顾性分析
Dig Dis. 2018;36(1):49-55. doi: 10.1159/000477613. Epub 2017 Jun 28.
10
Association of Anti-glycan Antibodies and Inflammatory Bowel Disease Course.糖抗原抗体与炎症性肠病病程的关系。
J Crohns Colitis. 2015 Jun;9(6):445-51. doi: 10.1093/ecco-jcc/jjv063. Epub 2015 Apr 19.

引用本文的文献

1
Advancing Therapeutic Targets in IBD: Emerging Goals and Precision Medicine Approaches.炎症性肠病治疗靶点的进展:新出现的目标与精准医学方法
Pharmaceuticals (Basel). 2025 Jan 10;18(1):78. doi: 10.3390/ph18010078.
2
Progression of Diabetic Kidney Disease and Gastrointestinal Symptoms in Patients with Type I Diabetes.1型糖尿病患者糖尿病肾病的进展及胃肠道症状
Biomedicines. 2023 Sep 29;11(10):2679. doi: 10.3390/biomedicines11102679.

本文引用的文献

1
Maximizing the diagnostic information from biopsies in chronic inflammatory bowel diseases: recommendations from the Erlangen International Consensus Conference on Inflammatory Bowel Diseases and presentation of the IBD-DCA score as a proposal for a new index for histologic activity assessment in ulcerative colitis and Crohn's disease.最大化慢性炎症性肠病活检的诊断信息:埃尔朗根国际炎症性肠病共识会议的建议以及IBD-DCA评分的介绍,作为溃疡性结肠炎和克罗恩病组织学活动评估新指标的提案
Virchows Arch. 2021 Mar;478(3):581-594. doi: 10.1007/s00428-020-02982-7. Epub 2020 Dec 29.
2
Disease Activity Patterns of Crohn's Disease in the First Ten Years After Diagnosis in the Population-based IBD South Limburg Cohort.发病十年内基于人群的炎症性肠病南林堡队列研究中克罗恩病的疾病活动模式。
J Crohns Colitis. 2021 Mar 5;15(3):391-400. doi: 10.1093/ecco-jcc/jjaa173.
3
Defining the Path Forward for Biomarkers to Address Unmet Needs in Inflammatory Bowel Diseases.定义生物标志物的前进道路,以满足炎症性肠病未满足的需求。
Inflamm Bowel Dis. 2020 Sep 18;26(10):1451-1462. doi: 10.1093/ibd/izaa210.
4
Gender Differences in Inflammatory Bowel Disease.性别差异与炎症性肠病。
Digestion. 2020;101 Suppl 1:98-104. doi: 10.1159/000504701. Epub 2020 Jan 29.
5
ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment.欧洲克罗恩病治疗指南:药物治疗
J Crohns Colitis. 2020 Jan 1;14(1):4-22. doi: 10.1093/ecco-jcc/jjz180.
6
Comparative Risk of Serious Infections With Biologic and/or Immunosuppressive Therapy in Patients With Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis.比较生物制剂和/或免疫抑制剂治疗炎症性肠病患者严重感染风险的系统评价和荟萃分析。
Clin Gastroenterol Hepatol. 2020 Jan;18(1):69-81.e3. doi: 10.1016/j.cgh.2019.02.044. Epub 2019 Mar 12.
7
Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases.炎症性肠病治疗相关的严重和机会性感染风险。
Gastroenterology. 2018 Aug;155(2):337-346.e10. doi: 10.1053/j.gastro.2018.04.012. Epub 2018 Apr 12.
8
Thiopurines in Inflammatory Bowel Disease: New Findings and Perspectives.炎症性肠病中的硫嘌呤:新发现与新视角。
J Crohns Colitis. 2018 Apr 27;12(5):610-620. doi: 10.1093/ecco-jcc/jjx181.
9
Epithelioid Granulomas Associate With Increased Severity and Progression of Crohn's Disease, Based on 6-Year Follow-Up.基于 6 年随访结果,上皮样肉芽肿与克罗恩病的严重程度和进展相关。
Clin Gastroenterol Hepatol. 2018 Jun;16(6):900-907.e1. doi: 10.1016/j.cgh.2017.12.034. Epub 2017 Dec 24.
10
Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial.紧密控制管理对克罗恩病(CALM)的影响:一项多中心、随机、对照的 3 期临床试验。
Lancet. 2017 Dec 23;390(10114):2779-2789. doi: 10.1016/S0140-6736(17)32641-7. Epub 2017 Oct 31.